The Form 4 filing, an SEC report of an insider’s stock trades, was filed on November 12, 2026. It covers sales made two days earlier by James Budge, Hinge Health’s chief financial officer.
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-11-10 |
| Date of Latest Transaction | 2026-11-10 |
| Buy/Sell | sell |
| Transaction Count | 5 |
| Shares Transacted | 35,907 |
| Price | $121.62 |
| Total Transaction Value | $4,367,052.29 |
| Insider | |
| Ticker Symbol | HNGE |
| Company | Hinge Health, Inc. |
| Insider Name | Budge James |
| Insider Title | Chief Financial Officer |
| Sector - Industry | Healthcare - Health Information Services |
| Holdings | |
| Total Shares Owned After Transaction | 256,207 |
| Position Size Change | 12.29% |
| Filing | |
| Filing Date | 2026-11-12 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
These were sales of HNGE shares, reported with transaction code S. The five sales involve one insider and appear in a single filing.
What was the average price of the transaction?
The average sale price was $121.62 per share, rounded to the nearest cent. Prices for each separate sale are not available in the transaction details.
How did this transaction affect the insider's holdings?
James Budge sold 35,907 shares and reported owning 256,207 shares afterward. The shares sold made up 12.29% of his reported shares owned before the sales.
What's the total transaction value?
The five sales had a total value of $4,367,052.29, rounded to the nearest cent. That amount covers all five transactions dated November 10, 2026.
Are there any special circumstances around this transaction?
The available information includes a Rule 10b5-1 trading-plan reference. These plans set trading instructions in advance. Footnote text was not provided, so it is unclear which of the five sales the reference covers. The plan’s start date, trading schedule, and other terms remain unknown.
For research purposes only; not investment advice.